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135 for internal exposure. Theses ions seem to be taken up 
by the cells. However more knowledge about the bio-kinetics 
of these auger emitters is needed to estimate the dose rates 
and the dose distribution in the cell. As the cells take up the 
Auger emitter, the dose rate by the internal Auger decays are 
continuously changing as a function of cellular accumulation 
and half-life of the isotope. 
Uptake curves are therefore produced by incubating HeLa 
cells with Auger-electron emitters for various amounts of 
time and with different levels of radioactivity to calculate 
the changing dose rate and accumulated dose.  These 
conditions will be mimicked as closely as possible with 
external γ-rays, by moving the cells closer to the source (Cs-
137). DNA damage will be assessed by flow cytometry 
measurements (MUSE) of phosphorylated histone H2AX (γ-
H2AX) and/or the clonogenic cell survival assay.  
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Purpose: The importance of MRI steadily increases in 
radiation oncology not only as multimodality imaging device 
but also as an implemented online imaging technology. 
Imaging using MRI shows advantages compared to CT or CBCT 
offering superior soft tissue contrast without additional dose. 
Also in particle beam therapy integrated MR guided 
treatment units have great potential. A complete 
understanding of the particle beam characteristics in the 
presence of magnetic fields is required. So far, studies in this 
area are limited. 
Material and Methods: Protons (60-250MeV) and carbon ions 
(120-400MeV/u) in the clinically required energy range 
impinging on a phantom of 35x35x50cm³ size were simulated 
using the MC framework GATE 7. Homogeneous magnetic 
fields of 0.35T, 1T and 3T perpendicular to the initial beam 
axis were applied. The beam deflection, shape, and the 
energy spectrum at the Bragg peak area was analyzed. A 
numerical algorithm was developed for deflection curve 
generation solving the relativistic equations of motion taking 
into account the Lorentz force and particle energy loss. 
Additionally, dose variations on material boundaries induced 
by magnetic fields were investigated for 250MeV protons. 
Results: Transverse deflections up to 99mm were observed 
for 250MeV protons at 3T. Deflections for lower field 
strengths (e.g. future hybrid open-MRI proton delivery 
systems) yielded 12mm for 0.35T and 34mm for 1T. A change 
in the dose distribution at the Bragg-peak region was 
observed for protons. Energy spectrum analysis showed an 
asymmetric lateral energy distribution. The different particle 
ranges resulted in a tilted dose distribution, see Fig.1.The 
numerical algorithm successfully modeled the deflection 
curve, with a maximum deviation of 1.8% and calculation 
times of less than 5ms. For a 250MeV proton beam passing in 
a 3T field through multiple slabs (water-air-water), only a 4% 
local dose increase at the first boundary was observed in 
single voxels due to the electron return effect, more than a 
factor 10 lower compared to a photon beam [1]. 
 
 
 
Fig1: Deformed 2D dose distribution at the Bragg peak area 
for a 250MeV proton beam in a 3T field 
 
Conclusion: Beam deflections in magnetic fields could be 
described by a numerical algorithm. The observed change in 
dose distribution in the Bragg-peak region has to be taken 
into account in future dose calculations. However, local dose 
changes due to boundary effects seem to be negligible for 
clinical applications. Current work in progress deals with the 
inclusion of magnetic field effects in a dose calculation 
algorithm for particles. 
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The mechanism of tumor cure by ionizing radiation is 
regarded tumor cell autonomous, effected by misrepair of 
radiation-induced DNA double strand breaks (DSBs), to a large 
extent via the function of error prone non-homologous end 
joining (NHEJ). This model prevails at the low dose range, 
with cure depending on tumor phenotypic propensity for 
NHEJ misrepair, and requires repeated exposures for tumor 
ablation.  Here we report high (>10Gy) single dose 
radiotherapy (SDRT) employs an alternative dual target 
model, inducing in addition to DSBs also an early wave of 
acid sphingomyelinase (ASMase)-mediated microcirculatory 
ischemia/reperfusion (I/R) injury. Reactive oxygen species 
(ROS) induced therein in parenchymal tumor cells disrupt 
activation of homology-directed repair (HDR), leading to 
catastrophic reprograming of DSB repair. We show Ku- and 
53BP1-mediated NHEJ are not affected, although 
MDC1/53BP1 resolution is delayed, while engagement of the 
HDR mediator cluster in DSB repair is aborted, promoting a 
divergent DSB repair pathway, generation of massive 
chromosomal alteration and reproductive tumor clonogen 
demise. Scavenging of ROS with the SOD-mimetic tempol 
reversed the loss-of-function HDR and tumor cell lethality, 
aborting tumor cure by SDRT. We define I/R-mediated loss-
of-function HDR as the detrimental SDRT damage response, 
